RecruitingPhase 3NCT06836557
Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis
A Multicenter, Open Label, 3-Month Safety Study with Tradipitant in Patients with Idiopathic or Diabetic Gastroparesis
Sponsor
Vanda Pharmaceuticals
Enrollment
100 participants
Start Date
Jan 9, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
This is a multicenter, open label, 3-month safety study with tradipitant in patients with idiopathic and diabetic gastroparesis.
Eligibility
Min Age: 18 YearsMax Age: 70 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a drug called Tradipitant for people with diabetic gastroparesis, gastroparesis, and other related conditions. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 18 Years to 70 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGTradipitant
BID
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06836557
Related Trials
Virtual Poetry Workshops to Enhance Patient Well Being and Reduce Anxiety
NCT077175411 location
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
NCT036037301 location
GI Neuromuscular Pathology Prospective Registry
NCT021650591 location
Indiana University Gastrointestinal Motility Diagnosis Registry
NCT045065931 location
Prokinetics and Body Surface Gastric Mapping in Dyspeptic Patients: Baseline and Treatment Effects
NCT068541203 locations